CAM
INSP icon

Cresset Asset Management’s Inspire Medical Systems INSP Stock Holding History

Cresset Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,195
Closed -$252K – 1979
2024
Q3 		$252K Buy
+1,195
New +$208K ﹤0.01% 1882
2024
Q2 		– Sell
-1,294
Closed -$278K – 2138
2024
Q1 		$278K Buy
+1,294
New +$254K ﹤0.01% 1630
2023
Q3 		– Sell
-2,019
Closed -$655K – 1888
2023
Q2 		$655K Buy
+2,019
New +$577K ﹤0.01% 1133

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cresset Asset Management's INSP Position: Q4 2024 in Review

Cresset Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2024, closing a stake of 1,195 shares — an estimated $252K sold.

Cresset Asset Management first reported a position in INSP in Q2 2023 and held it in 3 quarters. The position peaked at $655K in Q2 2023. 357 funds tracked by Wall St. Rank hold INSP as of Q4 2024.

  • Cresset Asset Management reported no remaining Inspire Medical Systems position as of Q4 2024 after selling out during the quarter.
  • Cresset Asset Management sold 1,195 Inspire Medical Systems shares in Q4 2024, an estimated $252K.
  • Cresset Asset Management first reported a position in Inspire Medical Systems in Q2 2023 and held it in 3 quarters.
  • Cresset Asset Management's Inspire Medical Systems position peaked at $655K in Q2 2023.
  • 357 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2024.

Based on Cresset Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.